Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 501NIH 107NETWORK 106INDUSTRY 44OTHER_GOV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Keratoacanthoma 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Methotrexate × Clear all
NCT04214626 2025-11-19

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02416388 2024-08-07

BIG-1

University Hospital, Angers

Phase 2/3 Recruiting
3,100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05315128 2022-04-07

Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

Zagazig University

Phase 2 Completed
60 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Keratoacanthoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡